Curia

Highly Engaged Employees

Curia, established in 1991 and formerly known as AMRI, operates as a premier contract research, development, and manufacturing organization (CDMO). The company provides comprehensive end-to-end solutions for pharmaceutical and biopharmaceutical clients, spanning the entire product lifecycle from initial research and development through to large-scale commercial manufacturing. By leveraging deep technical expertise, Curia supports complex drug development programs, ensuring high-quality delivery across global markets.

The organization maintains a robust operational footprint with 14 global locations, facilitating seamless integration between research and production facilities. Curia currently employs a workforce of 1,000-5,000 employees who drive innovation in drug discovery and manufacturing processes. Meet Curia's team to gain insights into the leadership and technical talent driving these operations. Their infrastructure is designed to meet stringent regulatory standards, providing clients with reliable, scalable manufacturing capabilities that accelerate time-to-market for critical therapeutic products.

In the competitive pharmaceutical and healthcare landscape, Curia generates annual revenue of $1.3B. The company competes with major industry players such as Catalent, Patheon Pharma Services, and Piramal Pharma Solutions. By focusing on specialized CDMO services, Curia maintains a strong market position, delivering value through advanced scientific capabilities and operational excellence. Their commitment to high-performance manufacturing and research services continues to attract a diverse portfolio of global biopharmaceutical partners, solidifying their role as a critical link in the modern drug development supply chain.